|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
0.3277 USD |
+2.21% | -3.62% | -56.72% | |
Published on 05/20/2025 at 17:05
Presenter Speech
Noella Alexander-Young (Executives)
Welcome to today’s presentation. My name is Noella Alexander-Young, Virtual Event Moderator here at Renmark Financial Communications.
O
|
ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 |
05:05pm |
|
|
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 |
09:51am |
CI |
|
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 |
Apr. 01 |
CI |
|
ProPhase Labs, Inc., 2024 Earnings Call, Mar 31, 2025 |
Mar. 31 |
|
|
Certain Pre-Funded Warrants of ProPhase Labs, Inc. are subject to a Lock-Up Agreement Ending on 8-MAR-2025. |
Mar. 07 |
CI |
|
Certain Common Stock of ProPhase Labs, Inc. are subject to a Lock-Up Agreement Ending on 8-MAR-2025. |
Mar. 07 |
CI |
|
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer |
Feb. 18 |
MT |
|
ProPhase Labs, Inc. Appoints Stu Hollenshead as Chief Operating Officer |
Feb. 18 |
CI |
|
ProPhase Labs, Inc. Announces Leaving of Jed Latkin as Chief Operating Officer |
Feb. 13 |
CI |
|
ProPhase Labs, Inc. announced that it expects to receive $7.730973 million in funding from Keystone Capital Partners LLC |
Jan. 28 |
CI |
|
An undisclosed buyer acquired Pharmaloz Manufacturing Inc. and Pharmaloz Real Estate Holdings, Inc. from ProPhase Labs, Inc. for approximately $23.6 million. |
Jan. 21 |
CI |
|
ProPhase Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 |
Nov. 13 |
CI |
|
ProPhase Labs, Inc., Q3 2024 Earnings Call, Nov 13, 2024 |
Nov. 13 |
|
|
Earnings Flash (PRPH) PROPHASE LABS Posts Q3 Revenue $3.1M |
Nov. 13 |
MT |
|
ProPhase Labs, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 |
Nov. 13 |
CI |
|
Top Midday Decliners |
Nov. 08 |
MT |
|
ProPhase Labs, Inc. Launches DNA Complete, Inc |
Nov. 04 |
CI |
|
ProPhase Labs, Inc. Announces Resignation of Eleanor Mcbrier as Director |
24-09-26 |
CI |
|
ProPhase Labs, Inc.(NasdaqCM:PRPH) dropped from S&P Global BMI Index |
24-09-22 |
CI |
|
Prophase Labs, Inc. Issues an Amended and Restated Unsecured Promissory Note and Guaranty |
24-08-22 |
CI |
|
ProPhase Labs, Inc., Q2 2024 Earnings Call, Aug 14, 2024 |
24-08-14 |
|
|
Earnings Flash (PRPH) PROPHASE LABS Posts Q2 Revenue $2.5M, vs. Street Est of $11.2M |
24-08-14 |
MT |
|
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 |
24-08-14 |
CI |
|
ProPhase Labs, Inc. Elects Eleanor McBrier to the Board of Directors |
24-06-21 |
CI |
|
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M |
24-05-09 |
MT |
PRPH: Dynamic Chart
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
